Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16001 - 16025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carbendazim	Investigational	MMP2	4313	downregulated	carbendazim results in decreased expression of MMP2 mRNA	16q12.2	A21554
Carbendazim	Investigational	MMP9	4318	downregulated	carbendazim results in decreased expression of MMP9 mRNA	20q13.12	A21554
Carbendazim	Investigational	PLAU	5328	downregulated	carbendazim results in decreased expression of PLAU mRNA	10q22.2	A21554
Carbendazim	Investigational	SERPINE2	5270	upregulated	carbendazim results in increased expression of SERPINE2 mRNA	2q36.1	A21554
Carbendazim	Investigational	TIMP1	7076	upregulated	carbendazim results in increased expression of TIMP1 mRNA	Xp11.3	A21554
Carbendazim	Investigational	TIMP2	7077	upregulated	carbendazim results in increased expression of TIMP2 mRNA	17q25.3	A21554
Carmustine	Approved Investigational	ACTC1	70	downregulated	Carmustine results in decreased expression of ACTC1 mRNA	15q14	A21555
Carmustine	Approved Investigational	ACTG2	72	downregulated	Carmustine results in decreased expression of ACTG2 mRNA	2p13.1	A21555
Carmustine	Approved Investigational	ACTN1	87	downregulated	Carmustine results in decreased expression of ACTN1 mRNA	14q24.1	A21555
Carmustine	Approved Investigational	ADAM15	8751	downregulated	Carmustine results in decreased expression of ADAM15 mRNA	1q21.3	A21555
Carmustine	Approved Investigational	ADAMTS4	9507	downregulated	Carmustine results in decreased expression of ADAMTS4 mRNA	1q23.3	A21555
Carmustine	Approved Investigational	ADCYAP1	116	downregulated	Carmustine results in decreased expression of ADCYAP1 mRNA	18p11.32	A21555
Carmustine	Approved Investigational	ADRA1B	147	downregulated	Carmustine results in decreased expression of ADRA1B mRNA	5q33.3	A21555
Carmustine	Approved Investigational	AKT2	208	downregulated	Carmustine results in decreased expression of AKT2 mRNA	19q13.2	A21555
Carmustine	Approved Investigational	ALAD	210	downregulated	Carmustine results in decreased expression of ALAD mRNA	9q32	A21555
Carmustine	Approved Investigational	ALOX15B	247	downregulated	Carmustine results in decreased expression of ALOX15B mRNA	17p13.1	A21555
Carmustine	Approved Investigational	AMH	268	downregulated	Carmustine results in decreased expression of AMH mRNA	19p13.3	A21555
Carmustine	Approved Investigational	APC2	10297	downregulated	Carmustine results in decreased expression of APC2 mRNA	19p13.3	A21555
Carmustine	Approved Investigational	APLNR	187	downregulated	Carmustine results in decreased expression of APLNR mRNA	11q12.1	A21555
Carmustine	Approved Investigational	AQP8	343	downregulated	Carmustine results in decreased expression of AQP8 mRNA	16p12.1	A21555
Carmustine	Approved Investigational	ARPC2	10109	downregulated	Carmustine results in decreased expression of ARPC2 mRNA	2q35	A21555
Carmustine	Approved Investigational	ARTN	9048	downregulated	Carmustine results in decreased expression of ARTN mRNA	1p34.1	A21555
Carmustine	Approved Investigational	ASMTL	8623	downregulated	Carmustine results in decreased expression of ASMTL mRNA	Xp22.3 and Yp11.3	A21555
Carmustine	Approved Investigational	ATP1A3	478	downregulated	Carmustine results in decreased expression of ATP1A3 mRNA	19q13.2	A21555
Carmustine	Approved Investigational	ATP4B	496	downregulated	Carmustine results in decreased expression of ATP4B mRNA	13q34	A21555

Displaying entries 16001 - 16025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability